rs1950897 — RAD51B RAD51B Intronic RA Susceptibility Variant

Intronic variant in RAD51B on chromosome 14; the T allele is associated with increased rheumatoid arthritis risk (OR ~1.10 per allele) in trans-ethnic GWAS, likely through effects on lymphocyte genomic stability and immune cell development mediated by RAD51B's role in homologous recombination DNA repair

See your personal result for RAD51B

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

RAD51B — When DNA Repair Goes Awry in Your Immune Cells

Deep within the bone marrow and lymph nodes, B and T lymphocytes undergo one of the most DNA-intensive processes in biology: V(D)J recombination11 V(D)J recombination
The molecular mechanism that generates the enormous diversity of antibodies and T-cell receptors by shuffling and rejoining gene segments — creating deliberate, programmed double-strand breaks in DNA that must be precisely repaired and somatic hypermutation. These processes require the cell's DNA repair machinery to work flawlessly — and that is exactly where RAD51B enters the picture. RAD51B encodes a member of the RAD51 family22 RAD51 family
A group of seven related proteins (RAD51, RAD51B, RAD51C, RAD51D, XRCC2, XRCC3, DMC1) all descended from the bacterial RecA recombinase; they cooperate to identify the homologous template strand needed for accurate DNA break repair that catalyzes homologous recombination repair of DNA double-strand breaks — the most dangerous form of DNA damage a cell can experience. The rs1950897 polymorphism, an intronic variant within RAD51B on chromosome 14, carries a T-allele that is associated with genome-wide significant rheumatoid arthritis (RA) risk across multiple ancestries and large meta-analyses.

The Mechanism

rs1950897 lies within an intron of RAD51B and does not change the protein sequence directly. Its functional consequence is most likely regulatory33 regulatory
Intronic variants can alter enhancer elements, splice-site efficiency, RNA secondary structure, or transcription factor binding within intronic regulatory regions, affecting how much protein the gene produces — possibly affecting RAD51B expression levels in specific cell types, altering RAD51B's availability for DNA repair in rapidly dividing lymphocytes.

RAD51B forms a heterodimer with RAD51C as part of the BCDX2 complex, which loads onto single-stranded DNA at sites of double-strand breaks and facilitates strand invasion — the critical first step of homologous recombination. In lymphocytes, this pathway is essential not only for V(D)J recombination and class-switch recombination but also for maintaining genomic stability as B and T cells undergo the massive proliferation triggered by antigen exposure. When RAD51B function is subtly compromised, double-strand break repair becomes error-prone, potentially generating neo-antigens, chromosomal translocations, or aberrant immune receptor gene arrangements that prime autoimmune activation. Separately, RAD51B variants have been shown to influence circulating interleukin-12 subunit beta44 interleukin-12 subunit beta
IL-12β is a component of IL-12 and IL-23 cytokines; IL-12 drives Th1 immune responses and IL-23 supports Th17 cells, both central to RA pathogenesis levels (rs1950897-T associated with higher IL-12β, p=4×10⁻¹⁰), providing a second mechanistic route — dysregulated cytokine output from immune cells — through which this locus may elevate autoimmune risk.

The Evidence

The RAD51B locus was established as an RA susceptibility locus in the landmark Okada et al. 2014 Nature trans-ethnic GWAS55 Okada et al. 2014 Nature trans-ethnic GWAS
Meta-analysis of more than 100,000 subjects across European and Asian ancestry; 29,880 RA cases and 73,758 controls in the largest RA genetic study at the time, which identified rs1950897 among 42 novel RA risk loci. The T allele carried an odds ratio of 1.10 (95% CI 1.07–1.13, p=8.2×10⁻¹¹) in the trans-ethnic analysis — a modest but robustly replicated effect. The locus was independently identified by McAllister et al. 201366 McAllister et al. 2013
Meta-analysis of 17,581 RA cases and 20,160 controls from the UK RA Genetics Consortium and RA Consortium International using proxy SNP rs911263 in the same locus (OR 0.89 for the protective allele in anti-CCP-positive RA patients, p=4×10⁻⁸), confirming that the RAD51B locus risk concentrates in the seropositive, ACPA-positive RA subtype.

Importantly, the RAD51B locus has been replicated in Asian populations. A Han Chinese study77 Han Chinese study
965 RA cases and 2,511 healthy controls genotyped for 62 RAD51B region SNPs found rs911263 strongly associated with both disease status (OR 0.64, p=4.8×10⁻⁵) and erosion severity (OR 0.52, p=2.89×10⁻⁵), suggesting that RAD51B not only predisposes to RA onset but influences the erosive, destructive course of established disease. A comprehensive review of RA genetics placing the locus in context of the full >100-SNP RA architecture gives rs1950897 an OR of 1.11 (95% CI 1.08–1.14) across combined ACPA-positive and ACPA-negative RA in European and Asian populations.

The rs1950897 locus also reaches genome-wide significance for IL-12 subunit beta levels (beta=0.08, p=4×10⁻¹⁰) and for hypothyroidism (OR 1.06, p=6×10⁻¹¹), indicating pleiotropy across autoimmune phenotypes. The T allele is notably more common in East Asian (88%) and South Asian (79%) populations than in Africans (24%), mirroring the ancestry-specific burden of RA susceptibility at this locus.

Practical Actions

For T allele carriers — which includes the majority of people of European, East Asian, and South Asian descent — the per-allele RA risk increase is modest and must be weighed against the full polygenic background. The clinical priority is early recognition of seropositive RA, which is the form most strongly linked to this locus. Anti-CCP antibody (ACPA) testing is the most specific biomarker for this subtype and can be positive years before clinical symptoms emerge.

Homozygous TT carriers have approximately 21% higher RA risk relative to CC at this single locus, but RA is a polygenic disease driven by dozens of interacting loci. The RAD51B locus contributes meaningfully to risk stratification when combined with HLA-DRB1 shared epitope status and PTPN22 rs2476601. TT homozygotes with additional RA risk variants warrant heightened awareness of inflammatory joint symptoms.

Interactions

The RAD51B rs1950897 locus operates independently of the HLA-DRB1 shared epitope, the strongest single RA genetic risk factor. In RA polygenic risk scoring, RAD51B risk compounds multiplicatively with other non-HLA loci including PTPN22 rs2476601 (T-cell activation threshold), TRAF1-C5 rs10818488 (NF-kB regulation), and STAT4 variants (type I interferon response). Proxy SNP rs911263 (chr14:68,286,876) and rs1885013 (chr14:68,287,978) are in high linkage disequilibrium with rs1950897 and tag the same RAD51B haplotype block; studies may report findings under any of these three rsids.

The locus's shared signal with IL-12β levels connects RAD51B risk to the IL-12/IL-23 cytokine axis, which is also regulated by STAT4 (rs7574865) and drives both Th1 and Th17 immune polarization. Individuals carrying risk alleles at both RAD51B and STAT4 may have compounding Th1/Th17 inflammatory bias.

Genotype Interpretations

What each possible genotype means for this variant.

CC Low-Risk Genotype Normal

Lowest-risk genotype at RAD51B rs1950897; no T-allele-driven RA risk at this locus

You carry two copies of the C (reference) allele at rs1950897 — the rarest genotype at this locus in most populations. Approximately 9% of people of European descent and 18% of Africans share this CC genotype. The T allele is the RA risk allele at this locus, and CC carriers do not carry T-allele-related RA susceptibility from RAD51B rs1950897. Interestingly, the C allele is the risk allele for asthma and allergic disease at this same locus, so this is a case where the RA-protective allele trades against respiratory allergy susceptibility — though the absolute allergy risk from this single locus remains modest (OR ~1.05).

CT One Risk Allele Intermediate

One copy of the T risk allele — modestly elevated RA risk at the RAD51B locus

The RAD51B rs1950897 locus is one of approximately 100 non-HLA susceptibility loci for RA, each contributing a modest per-allele effect. The CT genotype translates to roughly 10% elevated RA risk at this single locus; whether that risk becomes clinically meaningful depends on the aggregate polygenic burden, including HLA-DRB1 shared epitope status and PTPN22 rs2476601 (R620W).

RAD51B's role in homologous recombination repair in lymphocytes suggests that T-allele-driven changes in RAD51B expression could modestly impair DNA repair fidelity in activated B and T cells — contributing to chromosomal instability, neo-antigen generation, or aberrant immune activation. The same locus influences circulating IL-12 subunit beta levels, suggesting a concurrent effect on cytokine polarization toward the Th1 inflammatory phenotype characteristic of seropositive RA.

TT Two Risk Alleles High Risk

Two copies of the T risk allele — elevated RA susceptibility at the RAD51B locus

The TT genotype at rs1950897 places both chromosomal copies of RAD51B under the influence of the T allele's regulatory effects. The most directly established downstream consequence is elevated circulating interleukin-12 subunit beta levels (GWAS-significant, beta=0.08, p=4×10⁻¹⁰), consistent with RAD51B variants shifting immune cell cytokine output toward the pro-inflammatory Th1 polarization characteristic of seropositive RA.

Proxy SNP rs911263 at this locus — in high linkage disequilibrium with rs1950897 — showed an odds ratio of 0.64 for RA in a Han Chinese cohort (protective allele, meaning the risk allele roughly doubles the odds ratio at the locus level), and an OR of 0.52 for radiographic erosion severity, suggesting RAD51B genetic risk not only increases susceptibility to RA onset but accelerates joint destruction in established disease. This parallels the biology: if RAD51B function is subtly impaired, activated lymphocytes in the inflamed synovium accumulate DNA damage, potentially driving a more aggressive inflammatory and fibroblast-activating response.

The RAD51B locus also associates with hypothyroidism (T allele OR 1.06, p=6×10⁻¹¹), suggesting general autoimmune susceptibility that extends beyond the joints. TT carriers should be aware of the thyroid dimension as well.